| RS2125985283 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2125985473 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2125985854 |
UGT1A1
|
Health Risk |
Pathogenic |
— |
| RS2125986083 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2125986196 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125986279 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2125987009 |
covers 10 genes, none of which curated to show dosage sensitivity
|
Health Risk |
Pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome type 1 |
| RS2125987072 |
covers 10 genes, none of which curated to show dosage sensitivity
|
Health Risk |
Pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome type 1 |
| RS2125987779 |
UGT1A1
|
Health Risk |
Pathogenic |
Gilbert syndrome, Gilbert syndrome |
| RS2125989162 |
UGT1A1
|
Health Risk |
Pathogenic |
— |
| RS2125989471 |
UGT1A1
|
Health Risk |
Pathogenic |
Gilbert syndrome, Crigler-Najjar syndrome type 1 |
| RS2125989728 |
SCLT1
|
Health Risk |
Pathogenic |
— |
| RS2125989843 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2125990255 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2125990683 |
MLH1
|
Health Risk |
Pathogenic |
Colorectal cancer, hereditary nonpolyposis |
| RS2125990724 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125991063 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2125991131 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS2125991176 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2125991253 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2125991456 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS2125992965 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125993386 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2125993577 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2125993656 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2125993690 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2125993840 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2125996462 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2125996486 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome |
| RS2125996501 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Alport syndrome 3b |
| RS2125996545 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome 3b, autosomal recessive |
| RS2125996551 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2125996582 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2125996634 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2125997083 |
SCLT1
|
Health Risk |
Pathogenic |
— |
| RS2126003617 |
SCLT1
|
Health Risk |
Likely pathogenic |
— |
| RS2126010432 |
AFG2A
|
Health Risk |
Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS2126027812 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2126028189 |
FAT4
|
Health Risk |
Likely pathogenic |
— |
| RS2126029076 |
FAT4
|
Health Risk |
Pathogenic |
Van Maldergem syndrome 2, Van Maldergem syndrome 2 |
| RS2126030394 |
covers 10 genes, none of which curated to show dosage sensitivity
|
Health Risk |
Pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome type 1 |
| RS2126030563 |
UGT1A1
|
Health Risk |
Likely pathogenic |
— |
| RS2126030587 |
covers 10 genes, none of which curated to show dosage sensitivity
|
Health Risk |
Likely pathogenic |
— |
| RS2126034894 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS2126036604 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS2126036713 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS2126037181 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS2126038122 |
UGT1A1
|
Health Risk |
Pathogenic |
Gilbert syndrome, Gilbert syndrome |
| RS2126038220 |
UGT1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gilbert syndrome, Crigler-Najjar syndrome type 1 |
| RS2126038227 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS2126038249 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS2126048239 |
CASP10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 2A, Autoimmune lymphoproliferative syndrome type 2A |
| RS2126049633 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2126049787 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia 30 |
| RS2126049991 |
KIF1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS2126050077 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2126053905 |
CRBN
|
Health Risk |
Likely pathogenic |
— |
| RS2126054153 |
KIF1A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 30 |
| RS2126054169 |
KIF1A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory |
| RS2126054501 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia |
| RS2126062115 |
CASP10
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 2A, Autoimmune lymphoproliferative syndrome type 2A |
| RS2126062571 |
KIF1A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2126062641 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia 30 |
| RS2126062809 |
KIF1A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia 30 |
| RS2126069168 |
SCLT1
|
Health Risk |
Likely pathogenic |
— |
| RS2126069389 |
CRBN
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2126069391 |
SCLT1
|
Health Risk |
Likely pathogenic |
— |
| RS2126071436 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia 30 |
| RS2126071766 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2126071880 |
KIF1A
|
Health Risk |
Likely pathogenic |
— |
| RS2126083898 |
FAT4
|
Health Risk |
Likely pathogenic |
Hennekam lymphangiectasia-lymphedema syndrome 2, Hennekam lymphangiectasia-lymphedema syndrome 2 |
| RS2126091776 |
KIF1A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia 30 |
| RS2126091792 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2126147743 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia 30 |
| RS2126175345 |
COQ2
|
Health Risk |
Likely pathogenic |
— |
| RS2126175406 |
COQ2
|
Health Risk |
Pathogenic |
— |
| RS2126177139 |
COQ2
|
Health Risk |
Likely pathogenic |
Coenzyme Q10 deficiency, primary |
| RS2126178088 |
CFI
|
Health Risk |
Likely pathogenic |
Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency |
| RS2126187981 |
CYP2U1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 56, Hereditary spastic paraplegia 56 |
| RS2126190954 |
CFI
|
Health Risk |
Pathogenic |
— |
| RS2126199263 |
CYP2U1
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2126199411 |
CYP2U1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 56, Hereditary spastic paraplegia 56 |
| RS2126199530 |
CYP2U1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2126202736 |
CYP2U1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 56, Hereditary spastic paraplegia 56 |
| RS2126213962 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor I deficiency, CFI-related disorder |
| RS2126214430 |
CFI
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency |
| RS2126214475 |
CFI
|
Health Risk |
Pathogenic |
— |
| RS2126224367 |
CFI
|
Health Risk |
Pathogenic |
— |
| RS2126224371 |
CFI
|
Health Risk |
Pathogenic |
Factor I deficiency, Factor I deficiency |
| RS2126234459 |
HADH
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2126234552 |
HADH
|
Health Risk |
Likely pathogenic |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Deficiency of 3-hydroxyacyl-CoA dehydrogenase |
| RS2126274969 |
LEF1
|
Health Risk |
Pathogenic |
Ectrodactyly, Ectodermal dysplasia 17 with or without limb malformations |
| RS2126309189 |
ETFDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2126309523 |
ETFDH
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2126314844 |
ETFDH
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Glutaric acidemia type 2C |
| RS2126314946 |
ETFDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2126315337 |
ETFDH
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2126315444 |
ETFDH
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2126316172 |
ETFDH
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2126316486 |
ETFDH
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |